Harlan Radford
Director of Finance/CFO chez ALLAKOS INC.
Fortune : 385 584 $ au 31/03/2024
Profil
M. Harlan B. Radford, III, est directeur financier chez Allakos, Inc. Auparavant, M. Radford a occupé les postes de premier vice-président des finances chez Aimmune Therapeutics, Inc, de directeur financier chez HeartFlow, Inc, de vice-président des finances chez Intuitive Surgical, Inc, de directeur comptable intérimaire, vice-président et contrôleur chez eBay, Inc, de directeur comptable, vice-président et contrôleur chez eBay, Inc, et de vice-président des finances européennes chez PricewaterhouseCoopers LLP. Il a obtenu son diplôme de premier cycle à l'Université de l'Ohio.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ALLAKOS, INC.
0,35% | 06/03/2024 | 306 019 ( 0,35% ) | 385 584 $ | 31/03/2024 |
Postes actifs de Harlan Radford
| Sociétés | Poste | Début |
|---|---|---|
| ALLAKOS INC. | Director of Finance/CFO | 19/04/2021 |
Anciens postes connus de Harlan Radford
| Sociétés | Poste | Fin |
|---|---|---|
| AIMMUNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01/02/2021 |
HeartFlow, Inc.
 HeartFlow, Inc. Packaged SoftwareTechnology Services HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA. | Director of Finance/CFO | 01/01/2020 |
| INTUITIVE SURGICAL, INC. | Director of Finance/CFO | 01/07/2014 |
| EBAY INC. | Comptroller/Controller/Auditor | 01/08/2011 |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Corporate Officer/Principal | - |
Formation de Harlan Radford
| The Ohio University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| INTUITIVE SURGICAL, INC. | Health Technology |
| EBAY INC. | Retail Trade |
| ALLAKOS INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services PricewaterhouseCoopers LLC provides assurance, tax and advisory services. Its services include audit and assurance, consulting, deals, human resources, legal, tax, and family business. The firm also offers accountability, risk management, structuring, mergers and acquisitions, and performance and process improvement. The company was founded in 1998 and is headquartered in Buffalo, NY. | Commercial Services |
HeartFlow, Inc.
HeartFlow, Inc. Packaged SoftwareTechnology Services HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in 2007 and is headquartered in Redwood City, CA. | Technology Services |
Aimmune Therapeutics, Inc.
 Aimmune Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system. The firm product include Palforzia, which is an oral immunotherapy indicated for the mitigation of allergic reactions, including anaphylaxis that may occur with accidental exposure to peanut. The company was founded on June 24, 2011 and is headquartered in Brisbane, CA. | Health Technology |
